Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
in111-octreoscan (1 trial)
Ga 68 PSMA-11 (Illuccix) (1 trial)
Neuroendocrine Tumors (Phase 3)
Prostatic Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (2 total)